Profile | GDS5420 / 236108_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 133.2 | 46 |
GSM1296119 | B_lesional_pre-dose | 103.41 | 41 |
GSM1296076 | C_lesional_pre-dose | 131.82 | 47 |
GSM1296092 | D_lesional_pre-dose | 144.73 | 49 |
GSM1296103 | E_lesional_pre-dose | 120.26 | 45 |
GSM1296078 | F_lesional_pre-dose | 147.71 | 49 |
GSM1296107 | G_lesional_pre-dose | 110.9 | 41 |
GSM1296109 | H_lesional_pre-dose | 115.87 | 42 |
GSM1296080 | I_lesional_pre-dose | 127.94 | 47 |
GSM1296090 | J_lesional_pre-dose | 170.28 | 51 |
GSM1296074 | K_lesional_pre-dose | 130.1 | 48 |
GSM1296111 | L_lesional_pre-dose | 165.08 | 48 |
GSM1296099 | M_lesional_pre-dose | 90.15 | 40 |
GSM1296086 | O_lesional_pre-dose | 160.15 | 50 |
GSM1296117 | P_lesional_pre-dose | 68.5 | 33 |
GSM1296113 | Q_lesional_pre-dose | 99.75 | 38 |
GSM1296096 | R_lesional_pre-dose | 111.83 | 44 |
GSM1296105 | S_lesional_pre-dose | 117.49 | 43 |
GSM1296098 | T_lesional_pre-dose | 118.42 | 43 |
GSM1296101 | U_lesional_pre-dose | 138.32 | 46 |
GSM1296121 | V_lesional_pre-dose | 80.12 | 37 |
GSM1296088 | W_lesional_pre-dose | 166.01 | 50 |
GSM1296082 | X_lesional_pre-dose | 213.6 | 55 |
GSM1296115 | Y_lesional_pre-dose | 93.92 | 39 |
GSM1296084 | Z_lesional_pre-dose | 161.92 | 49 |
GSM1296072 | B_lesional_day8 | 114.14 | 42 |
GSM1296069 | L_lesional_day8 | 114.91 | 41 |
GSM1296071 | P_lesional_day8 | 115.74 | 41 |
GSM1296070 | Y_lesional_day8 | 96.79 | 38 |
GSM1296073 | V_lesional_day8 | 95.87 | 40 |
GSM1296034 | A_lesional_day15 | 129.97 | 44 |
GSM1296041 | G_lesional_day15 | 122.55 | 43 |
GSM1296035 | R_lesional_day15 | 137.44 | 47 |
GSM1296038 | U_lesional_day15 | 137.88 | 46 |
GSM1296047 | B_lesional_day15 | 100.68 | 39 |
GSM1296039 | E_lesional_day15 | 97.45 | 41 |
GSM1296042 | H_lesional_day15 | 137.76 | 44 |
GSM1296043 | L_lesional_day15 | 134.29 | 43 |
GSM1296037 | M_lesional_day15 | 85.82 | 38 |
GSM1296046 | P_lesional_day15 | 65.14 | 31 |
GSM1296044 | Q_lesional_day15 | 104.6 | 39 |
GSM1296045 | Y_lesional_day15 | 113.31 | 40 |
GSM1296025 | C_lesional_day15 | 96.79 | 41 |
GSM1296033 | D_lesional_day15 | 174.18 | 50 |
GSM1296027 | I_lesional_day15 | 300.49 | 60 |
GSM1296032 | J_lesional_day15 | 130.77 | 45 |
GSM1296024 | K_lesional_day15 | 117.11 | 45 |
GSM1296031 | W_lesional_day15 | 129.73 | 45 |
GSM1296028 | X_lesional_day15 | 220.41 | 54 |
GSM1296029 | Z_lesional_day15 | 173.48 | 50 |
GSM1296026 | F_lesional_day15 | 120.32 | 45 |
GSM1296030 | O_lesional_day15 | 170.86 | 52 |
GSM1296040 | S_lesional_day15 | 205.84 | 53 |
GSM1296036 | T_lesional_day15 | 132.97 | 45 |
GSM1296048 | V_lesional_day15 | 65.79 | 33 |
GSM1296059 | A_lesional_day43 | 139.88 | 47 |
GSM1296066 | G_lesional_day43 | 92.91 | 38 |
GSM1296060 | R_lesional_day43 | 95.62 | 41 |
GSM1296063 | U_lesional_day43 | 90.46 | 39 |
GSM1296064 | E_lesional_day43 | 103.66 | 43 |
GSM1296067 | H_lesional_day43 | 84.83 | 36 |
GSM1296062 | M_lesional_day43 | 130.84 | 45 |
GSM1296068 | Q_lesional_day43 | 61.25 | 29 |
GSM1296050 | C_lesional_day43 | 89.03 | 39 |
GSM1296057 | D_lesional_day43 | 111.03 | 43 |
GSM1296052 | I_lesional_day43 | 213.59 | 55 |
GSM1296054 | J_lesional_day43 | 115.61 | 43 |
GSM1296049 | K_lesional_day43 | 113.29 | 44 |
GSM1296055 | W_lesional_day43 | 115.69 | 43 |
GSM1296053 | X_lesional_day43 | 270.33 | 57 |
GSM1296058 | Z_lesional_day43 | 92.31 | 41 |
GSM1296051 | F_lesional_day43 | 111.36 | 44 |
GSM1296056 | O_lesional_day43 | 106.79 | 44 |
GSM1296065 | S_lesional_day43 | 122.36 | 44 |
GSM1296061 | T_lesional_day43 | 87.03 | 39 |
GSM1296095 | A_non-lesional_pre-dose | 87.7 | 40 |
GSM1296120 | B_non-lesional_pre-dose | 78.95 | 35 |
GSM1296077 | C_non-lesional_pre-dose | 186.75 | 52 |
GSM1296093 | D_non-lesional_pre-dose | 101.33 | 41 |
GSM1296104 | E_non-lesional_pre-dose | 100.9 | 41 |
GSM1296079 | F_non-lesional_pre-dose | 114.01 | 44 |
GSM1296108 | G_non-lesional_pre-dose | 101.37 | 40 |
GSM1296110 | H_non-lesional_pre-dose | 116.4 | 41 |
GSM1296081 | I_non-lesional_pre-dose | 217.07 | 55 |
GSM1296091 | J_non-lesional_pre-dose | 189 | 52 |
GSM1296075 | K_non-lesional_pre-dose | 112.92 | 45 |
GSM1296112 | L_non-lesional_pre-dose | 126.17 | 42 |
GSM1296100 | M_non-lesional_pre-dose | 174.5 | 49 |
GSM1296087 | O_non-lesional_pre-dose | 341.31 | 62 |
GSM1296118 | P_non-lesional_pre-dose | 80.96 | 35 |
GSM1296114 | Q_non-lesional_pre-dose | 72.34 | 33 |
GSM1296097 | R_non-lesional_pre-dose | 73.46 | 37 |
GSM1296106 | S_non-lesional_pre-dose | 117.6 | 43 |
GSM1296102 | U_non-lesional_pre-dose | 94.98 | 39 |
GSM1296122 | V_non-lesional_pre-dose | 66.41 | 33 |
GSM1296089 | W_non-lesional_pre-dose | 112.95 | 42 |
GSM1296083 | X_non-lesional_pre-dose | 166.56 | 49 |
GSM1296116 | Y_non-lesional_pre-dose | 126.77 | 42 |
GSM1296085 | Z_non-lesional_pre-dose | 209.81 | 53 |